Verseon Corporation Result of 2019 AGM (4392R)
29 Octobre 2019 - 8:00AM
UK Regulatory
TIDMVERS
RNS Number : 4392R
Verseon Corporation
29 October 2019
October 29, 2019
Verseon Corporation
("Verseon" or the "Company")
Result of 2019 AGM
Fremont, Calif.-Verseon Corporation (AIM: VERS), a
clinical-stage pharmaceutical company, announces that all
resolutions put to shareholders during the Annual General Meeting
("AGM") held on October 28, 2019 at 9:00 am PDT were duly
passed.
-Ends-
For further information, please contact
Verseon Corporation www.verseon.com
Sebastian Wykeham / Tina Schlafly +1 (510) 225 9000
Arden Partners (NOMAD and Broker)
Ruari McGirr / Ciaran Walsh / Dan Gee-Summons
(Corporate Finance) / Fraser Marshall +44 (0) 20 7614
(Equity Sales) 5900
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737 821
Simon Vane Percy 890
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGPGGWAUUPBUAB
(END) Dow Jones Newswires
October 29, 2019 03:00 ET (07:00 GMT)
Verseon (LSE:VERS)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Verseon (LSE:VERS)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024
Real-Time news about Verseon Corporation (London Stock Exchange): 0 recent articles
Plus d'articles sur Verseon Corporation